Uncertainties in the management of the Zollinger-Ellison Syndrome.
D002927:Cimetidine / Q000627:therapeutic use; D005663:Furans / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D011899:Ranitidine; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy*
D005663:Furans; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D002927:Cimetidine; D011899:Ranitidine